The invention relates to the use of composition comprising free amino acids as a sole source of protein, a fatty acid source comprising long chain polyunsaturated fatty acids, a carbohydrate source comprising digestible and indigestible carbohydrates, and milk protein free Bifidobacteria for treating a person suffering from (a) colic, congestion, runny nose, wheezing, vomiting, diarrhea, bloody stools, mucus in stools, rash, eczema, gastroesophageal reflux, eosinophilic esophagitis or asthma; (b) cow's milk allergy and/or food protein intolerance; and/or (c) infections, wherein the indigestible carbohydrate is selected from a milk protein free source and the total composition is essentially free of intact proteins.

Langford; Jane Elizabeth

Sullivan; Ian

Deering; Catherine Teresa

Giffen; Sandra Helen

SHS International

Protein free formula

The invention relates to a stable pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD) and a novel micronisation process for manufacturing a stable formulation for formoterol or its enantiomers and a carrier/diluent comprising a carbohydrate such as lactose.

AstraZeneca AB

Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent

The invention relates to a stable pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD) and a novel micronization process for manufacturing a stable formulation for formoterol or its enantiomers and a carrier/diluent comprising a carbohydrate such as lactose.

rhinitis/carbohydrate

Protein free formula

Pharmaceutical composition containing an active ingredient and a micronised carrier/diluent

Process for preparing a pharmaceutical composition containing an active ingredient and a micronised carrier/diluent

O mais completo banco de dados de ervas medicinais apoiado pela ciência